Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Abbott Laboratories    ABT   US0028241000

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Abbott Laboratories : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Sales38 85139 87421 84822 50023 74225 078
Operating income (EBITDA)11 21612 6164 9745 5425 9996 452
Operating profit (EBIT)9 0109 8334 0464 1614 6304 949
Pre-Tax Profit (EBT)5 1996 2632 521---
Net income4 7295 9632 5762 6503 1213 555
EPS ( $)3,013,721,621,652,002,31
Dividend per Share ( $)1,881,67-0,850,991,10
Yield4,87%4,33%-2,21%2,55%2,85%
Announcement Date01/25/2012
12:46pm
01/23/2013
12:47pm
01/22/2014
12:44pm
---
Finances - Leverage
Abbott Laboratories : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Debt8 6029 674-1 8251 137-
Finance-----932
Operating income (EBITDA)11 21612 6164 9745 5425 9996 452
Leverage
(Debt/EBITDA)
0,77x0,77x-0,33x0,19x-
Capital Expenditure1 4921 795-1 1911 0991 278
Book Value Per Share (BVPS)15,6 $17,0 $16,3 $16,3 $17,2 $18,7 $
Cash Flow per Share5,72 $5,85 $-2,56 $2,80 $3,01 $
Announcement Date01/25/2012
12:46pm
01/23/2013
12:47pm
01/22/2014
12:44pm
---
Balance Sheet Analysis
Abbott Laboratories : Balance Sheet Analysis
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 59 563 M$ -
Company Value 61 388 M$ 60 699 M$
Valuation 2014e 2015e
PER (Price / EPS) 23,4x 19,3x
Capitalization / Revenue 2,65x 2,51x
EV / Revenue 2,73x 2,56x
EV / EBITDA 11,1x 10,1x
Yield (DPS / Price) 2,21% 2,55%
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 18,5% 19,5%
operating Leverage (Delta EBIT / Delta Sales) 0,95x 2,05x
Net Margin (Net Profit / Revenue) 11,8% 13,1%
ROA (Net Profit / Asset) 7,46% 7,80%
ROE (Net Profit / Equities) 13,1% 13,5%
Rate of Dividend 51,7% 49,4%
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   5,29% 4,63%
Cash Flow / Sales (Taux d'autofinancement) 17,6% 18,2%
Capital Intensity (Assets / Sales) 1,58x 1,69x
Financial Leverage (Net Debt / EBITDA) 0,33x 0,19x
Price Earning Ratio
Abbott Laboratories : Price Earning Ratio
EPS & Dividend
Abbott Laboratories : EPS Dividend
Dynamic quotes  
ON
| OFF